You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced metastatic soft tissue sarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

Soft Tissue Sarcoma Trial (Candonilimab)

Not yet recruiting
  • Soft Tissue Sarcoma
  • (no location specified)
Jun 22, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Soft Tissue Sarcoma Trial in New York (Tigilanol Tiglate)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Tigilanol Tiglate
  • New York, New York
    Memorial Sloan Kettering Cancer Centre
Mar 2, 2023

Sarcoma, Soft Tissue Trial in Berlin, Munich (DPPG2-TSL-DOX)

Recruiting
  • Sarcoma, Soft Tissue
  • Berlin, Germany
  • +1 more
May 12, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

Recruiting
  • Sarcoma
  • +2 more
  • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023

Soft Tissue Sarcoma, Bone Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate, Gemcitabine)

Not yet recruiting
  • Soft Tissue Sarcoma
  • +5 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 16, 2022

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 10, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Soft Tissue Sarcoma Trial in Copenhagen (LTX-315 and TILs)

Active, not recruiting
  • Soft Tissue Sarcoma
  • LTX-315 and TILs
  • Copenhagen, Denmark
    Herlev Hospital
Aug 27, 2021

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Pembrolizumab)

Active, not recruiting
  • Soft Tissue Sarcoma
  • Boston, Massachusetts
  • +5 more
Jul 19, 2022

Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Metastatic Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Research Center
May 4, 2022

Soft Tissue Sarcoma Trial in Münster (Dacarbazine, onfekafusp alfa)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +15 more
Dec 22, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Soft Tissue Sarcoma Trial in Stanford (Ipilimumab, Cryoablation, Nivolumab)

Active, not recruiting
  • Soft Tissue Sarcoma
  • Stanford, California
    Stanford Medical Center
Feb 2, 2022

Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)

Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma Trial in Iowa City (Ascorbate)

Recruiting
  • Sarcoma
  • +4 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Feb 9, 2022

Sarcoma, Soft Tissue Trial in Orange (Pembrolizumab, Stereotactic body radiation therapy)

Recruiting
  • Sarcoma, Soft Tissue
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 9, 2022

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023